329 related articles for article (PubMed ID: 28830266)
1. Using biomarkers to guide heart failure management.
Chang KW; Fox S; Mojaver S; Maisel AS
Expert Rev Cardiovasc Ther; 2017 Oct; 15(10):729-741. PubMed ID: 28830266
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers and diagnostics in heart failure.
Gaggin HK; Januzzi JL
Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
[TBL] [Abstract][Full Text] [Related]
3. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
Ibrahim N; Januzzi JL
Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
[TBL] [Abstract][Full Text] [Related]
4. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide guided heart failure management.
Mohammed AA; Januzzi JL
Curr Clin Pharmacol; 2009 May; 4(2):87-94. PubMed ID: 19442073
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptide-guided heart failure management.
Troughton R; Michael Felker G; Januzzi JL
Eur Heart J; 2014 Jan; 35(1):16-24. PubMed ID: 24216390
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for the diagnosis and management of heart failure.
Castiglione V; Aimo A; Vergaro G; Saccaro L; Passino C; Emdin M
Heart Fail Rev; 2022 Mar; 27(2):625-643. PubMed ID: 33852110
[TBL] [Abstract][Full Text] [Related]
9. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
Brunner-La Rocca HP; Eurlings L; Richards AM; Januzzi JL; Pfisterer ME; Dahlström U; Pinto YM; Karlström P; Erntell H; Berger R; Persson H; O'Connor CM; Moertl D; Gaggin HK; Frampton CM; Nicholls MG; Troughton RW
Eur J Heart Fail; 2015 Dec; 17(12):1252-61. PubMed ID: 26419999
[TBL] [Abstract][Full Text] [Related]
10. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides in heart failure and acute coronary syndrome.
Gaggin HK; Januzzi JL
Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
[TBL] [Abstract][Full Text] [Related]
12. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in acute heart failure.
Mallick A; Januzzi JL
Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):514-25. PubMed ID: 25911167
[TBL] [Abstract][Full Text] [Related]
16. Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does "X" Really Mark the Spot?
Logan JK; Mentz RJ
Curr Heart Fail Rep; 2019 Dec; 16(6):250-256. PubMed ID: 31741230
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of natriuretic peptide-guided treatment of chronic heart failure. A meta-analysis.
Gamiño-Arroyo AE; Prado-Galbarro FJ; García-Pérez S; Sánchez-Piedra C
Arch Cardiol Mex; 2018; 88(3):171-177. PubMed ID: 28408177
[TBL] [Abstract][Full Text] [Related]
18. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
19. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
20. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure.
Gruson D; Ahn SA; Rousseau MF
Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]